GGrantIndex
Sort

64,565 grants matching drug discovery

Development of Innovative Resources to Advance MDS Research

$1,574,993
Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2025 · DK

Development of Innovative Resources to Advance MDS Research

$1,574,980
Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2023 · DK

Medical Scientist Training Program

$1,574,716
Christopher S. Williams · Vanderbilt University · T32 · FY2025 · GM

Nephrotic Syndrome Rare Disease Clinical Research Network III

$1,574,136
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2020 · DK

Human pluripotent stem cells

$1,573,768
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS

NATIONAL BIOMEDICAL COMPUTATION RESOURCE

$1,573,657
Rommie E Amaro · University Of California, San Diego · P41 · FY2015 · GM

Developing GPR37 activators as non-opioid pain therapeutics

$1,573,491
Jun-Ho La · University Of Texas Med Br Galveston · R61 · FY2022 · NS

CTSA K12 Program at the University of Alabama at Birmingham

$1,573,065
Kenneth G Saag · University Of Alabama At Birmingham · K12 · FY2025 · TR

The Psychophysiology of Fear and Anxiety

$1,572,969
Christian Grillon · National Institute Of Mental Health · ZIA · FY2022 · MH

Pathway discovery, validation and compound identification for Alzheimer's disease

$1,572,897
Philip L De Jager · Broad Institute, Inc. · U01 · FY2016 · AG

Discovery and validation of genetic variants affecting microglial activation in Alzheimer's disease

$1,572,761
Philip L De Jager · Columbia University Health Sciences · R01 · FY2024 · AG

Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection

$1,572,419
Caroline E Cameron · University Of Victoria · U01 · FY2025 · AI

New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders

$1,571,137
Simon Vu · Equator Therapeutics, Inc. · R44 · FY2025 · DK

New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders

$1,571,137
Simon Vu · Equator Therapeutics, Inc. · R44 · FY2024 · DK

Chemistry and Synthesis Center (formerly IPDC)

$1,570,963
Rolf Swenson · National Heart, Lung, And Blood Institute · ZIC · FY2025 · HL

Expression Genetics in Drug Therapy

$1,570,156
Wolfgang Sadee · Ohio State University · U01 · FY2011 · GM

Disease mechanism and therapies for retinal degeneration

$1,569,922
Tiansen Li · National Eye Institute · ZIA · FY2018 · EY

BOTANICAL DIETARY SUPPLEMENTS FOR WOMEN'S HEALTH

$1,568,341
University Of Illinois At Chicago · P50 · FY2003 · AT

Deciphering the mechanisms mediating the dichotomous effects of fever on brain function and behavior

$1,567,514
Michelle Antoine · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

Building an Implantable Artificial Kidney

$1,566,286
Shuvo Roy · University Of California, San Francisco · U01 · FY2016 · EB

Biomolecular Structure and Mechanism, Structure-Based Drug Design

$1,565,829
Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis

$1,565,814
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · AR

NCI-Frederick Support and Technical Services

$1,565,760
Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2011 · CA

Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics

$1,563,778
Seok-Yong Lee · Duke University · R61 · FY2024 · NS

Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis

$1,563,264
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · AR